Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes.
about
A New Outlook on Mental Illnesses: Glial Involvement Beyond the GlueThe Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific TreatmentsFunctional alterations of astrocytes in mental disorders: pharmacological significance as a drug targetAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceSignal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood DisordersDrug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosisChronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.Monoaminergic Control of Cellular Glucose Utilization by Glycogenolysis in Neocortex and Hippocampus.The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment.Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic/growth factors: differential regulation of FGF-2 by noradrenalineTricyclic antidepressant amitriptyline indirectly increases the proliferation of adult dentate gyrus-derived neural precursors: an involvement of astrocytes.1H NMR-based metabolic profiling reveals the effects of fluoxetine on lipid and amino acid metabolism in astrocytes.Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex.Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus.Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorderModels of multiple system atrophyBDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disordersA Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation.Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1.Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes.White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosisAspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation.The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics.Fluoxetine pharmacogenetics in child and adult populations.5-HT2 ligands in the treatment of anxiety and depression.Strategies for early stroke recovery: what lies ahead?Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression.Targeting astrocytes in major depression.Pharmacological modulation of astrocytes and the role of cell type-specific histone modifications for the treatment of mood disordersPromoting recovery from ischemic stroke.Fermented Brown Rice Extract Stimulates BDNF Gene Transcription in C6 Glioma Cells: Possible Connection with HO-1 Expression.Spirulina non-protein components induce BDNF gene transcription via HO-1 activity in C6 glioma cells.An astroglial basis of major depressive disorder? An overview.Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.Apolipoprotein E Mimetic Peptide Increases Cerebral Glucose Uptake by Reducing Blood-Brain Barrier Disruption after Controlled Cortical Impact in Mice: An 18F-Fluorodeoxyglucose PET/CT Study.
P2860
Q26770756-A0B798FC-13F4-435C-B838-C64999350EF2Q26783012-7F5C3C8D-C1F8-4755-8805-00913A1B2830Q26798948-00C1EC80-AE4C-47E4-94F3-8C7BBBD573E4Q26827833-DF7689E9-B2B9-4AB9-A6B8-61D9A4C49E68Q26999061-131AE46C-9CA7-4936-85D8-C019E9E3BCABQ27006485-CD166422-3B0F-4F59-97F2-C7A2EB5A9159Q28545984-51A2474F-F490-4352-B13C-524EE7B8A7ABQ30906677-CDA21F80-1CCE-4411-8177-31E29E8ADE4AQ30980023-2F9866B8-4225-40C0-B7F3-6450E1E09B0FQ33635626-B57B91BF-818C-4D23-B7BB-0739404A88FFQ34391633-187578BA-DC9F-4DCF-AEAE-663AA4775D27Q34507303-A7AB5316-70CE-4DB1-8ECE-E88C9E7C60B2Q35048386-F4A1CE54-7474-4A28-BD3A-CCB56FA43271Q35585693-D7163DC3-967B-49BD-B309-733BD4ED1C71Q36147115-EC3C6495-3460-405E-B250-9C26028BEDA4Q36301537-B274769F-1D38-4B55-9C04-5A05FCEDBF43Q36434538-491E64D6-5B87-45A6-A2EB-CA5A66972E67Q36513407-01360ADE-9126-477C-B1C7-9D995A1F3F0DQ36809785-E4B6EBDF-2E9C-4760-9446-5286ABDA68F0Q36944201-84DEF7A9-C948-4250-847D-9057416668ABQ36993596-0BE1F6F0-0EDF-457C-9176-CB30D95285F6Q37364186-1F636708-B888-4283-A2C3-D6BD3CF51F90Q37597918-EF43D807-E2DE-4C15-974C-88DCAC18A01FQ37634525-DFE0AC65-7E94-487F-B8E0-FB080D0A675AQ37972980-34A8DBF6-9839-4815-B09A-729096985485Q37995668-D7D949F0-E4BA-4AF8-A5C1-BE43068CE9A1Q38004705-11342E87-CB5D-440D-BF30-5B4EB700F1A1Q38015254-36DA5737-5727-4352-BC6B-45A3D79D0732Q38025986-F0CD3988-D529-4E48-8396-C80A77E50EC7Q38037141-F3FD0480-0CAE-4815-8A3A-63A8AF72A48FQ38268307-F70AB9A0-AC3B-4226-95DC-EA6A16E1AEB1Q38407791-DEFE58D6-0C70-4C7E-A228-1637C9649823Q38608401-ED105034-0E1C-468C-A4A8-5B79D96E19A6Q38619770-0D28EBCB-8DC8-46DD-8476-355CC27A6FBCQ38675024-83C44600-4E34-4480-9820-5F5526E6C34DQ38750158-82118CA0-0DAE-4F62-8674-666F7C157C1BQ38944693-D584DC1F-66D4-46BD-BC65-7D359C47D327Q39186841-E5F2E88F-A8CB-4A7B-8DD2-CCC77AB83C1FQ39405702-E1406F9F-1EA8-4D97-A1A4-3A6EBB299B28Q39605358-ED88FB34-6C48-4CBA-AEC3-DD841D5F7CAD
P2860
Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Fluoxetine regulates the expre ...... cose metabolism in astrocytes.
@en
Fluoxetine regulates the expre ...... cose metabolism in astrocytes.
@nl
type
label
Fluoxetine regulates the expre ...... cose metabolism in astrocytes.
@en
Fluoxetine regulates the expre ...... cose metabolism in astrocytes.
@nl
prefLabel
Fluoxetine regulates the expre ...... cose metabolism in astrocytes.
@en
Fluoxetine regulates the expre ...... cose metabolism in astrocytes.
@nl
P2860
P50
P1433
P1476
Fluoxetine regulates the expre ...... cose metabolism in astrocytes.
@en
P2093
Hubert Fiumelli
P2860
P2888
P356
10.1007/S00213-011-2190-Y
P577
2011-02-08T00:00:00Z
P5875
P6179
1032888760